Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1256

1.

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.

Schwartz GG, Bessac L, Berdan LG, Bhatt DL, Bittner V, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Rorick T, Sasiela WJ, Shirodaria C, Szarek M, Tamby JF, Tricoci P, White H, Zeiher A, Steg PG.

Am Heart J. 2014 Nov;168(5):682-9. doi: 10.1016/j.ahj.2014.07.028. Epub 2014 Aug 7.

PMID:
25440796
[PubMed - indexed for MEDLINE]
Free Article
2.

Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.

Du Y, Sun H, Li Y, Shi X, Pei D, Qi D, Wang B.

Clin Lab. 2014;60(8):1295-300.

PMID:
25185414
[PubMed - indexed for MEDLINE]
3.

The role of exercise training on lipoprotein profiles in adolescent males.

Koozehchian MS, Nazem F, Kreider RB, Roberts WJ, Best TM, Rong Y, Zuo L.

Lipids Health Dis. 2014 Jun 9;13:95. doi: 10.1186/1476-511X-13-95.

PMID:
24912476
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.

Farnier M, Chen E, Johnson-Levonas AO, McCrary Sisk C, Mitchel YB.

Vasc Health Risk Manag. 2014 May 7;10:279-90. doi: 10.2147/VHRM.S58694. eCollection 2014.

PMID:
24855368
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.

Rinne P, Silvola JM, Hellberg S, Ståhle M, Liljenbäck H, Salomäki H, Koskinen E, Nuutinen S, Saukko P, Knuuti J, Saraste A, Roivainen A, Savontaus E.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1346-54. doi: 10.1161/ATVBAHA.113.302963. Epub 2014 May 1.

PMID:
24790139
[PubMed - indexed for MEDLINE]
6.

High-density lipoproteins: taking the good with the bad.

Sparks CE, Corsetti JP, Sparks JD.

Curr Opin Lipidol. 2014 Jun;25(3):230-2. doi: 10.1097/MOL.0000000000000079. No abstract available.

PMID:
24763089
[PubMed - indexed for MEDLINE]
7.

Hypobetalipoproteinemia and abetalipoproteinemia.

Welty FK.

Curr Opin Lipidol. 2014 Jun;25(3):161-8. doi: 10.1097/MOL.0000000000000072. Review.

PMID:
24751931
[PubMed - indexed for MEDLINE]
8.

Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials.

Thanassoulis G, Williams K, Ye K, Brook R, Couture P, Lawler PR, de Graaf J, Furberg CD, Sniderman A.

J Am Heart Assoc. 2014 Apr 14;3(2):e000759. doi: 10.1161/JAHA.113.000759.

PMID:
24732920
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis.

Vuorio T, Nurmi H, Moulton K, Kurkipuro J, Robciuc MR, Ohman M, Heinonen SE, Samaranayake H, Heikura T, Alitalo K, Ylä-Herttuala S.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1162-70. doi: 10.1161/ATVBAHA.114.302528. Epub 2014 Apr 10.

PMID:
24723556
[PubMed - indexed for MEDLINE]
10.

What is new in familial hypercholesterolemia?

Santos RD, Maranhao RC.

Curr Opin Lipidol. 2014 Jun;25(3):183-8. doi: 10.1097/MOL.0000000000000073. Review.

PMID:
24699416
[PubMed - indexed for MEDLINE]
11.

Cardiometabolic implications of postpartum weight changes in the first year after delivery.

Kew S, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R.

Diabetes Care. 2014 Jul;37(7):1998-2006. doi: 10.2337/dc14-0087. Epub 2014 Mar 25.

PMID:
24667457
[PubMed - indexed for MEDLINE]
12.

Influence of vanadium on serum lipid and lipoprotein profiles: a population-based study among vanadium exposed workers.

Zhang Y, Zhang Q, Feng C, Ren X, Li H, He K, Wang F, Zhou D, Lan Y.

Lipids Health Dis. 2014 Feb 24;13:39. doi: 10.1186/1476-511X-13-39.

PMID:
24558984
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Association between nontraditional risk factors and metabolic syndrome in indigenous Argentinean schoolchildren.

Hirschler V, Maccallini G, Molinari C, Urrutia IM, Castano On Behalf Of The San Antonio de Los Cobres Study Group LA.

Diabetes Technol Ther. 2014 Feb;16(2):84-90. doi: 10.1089/dia.2013.0239.

PMID:
24428355
[PubMed - indexed for MEDLINE]
14.

The potential of Cystatin C and small dense LDL as biomarkers of coronary artery disease risk in a young Indian population.

Manocha A, Gupta F, Jain R, Bhargava S, Kankra M, Das S, Srivastava LM.

Mol Cell Biochem. 2014 Apr;389(1-2):59-68. doi: 10.1007/s11010-013-1927-9. Epub 2013 Dec 20.

PMID:
24357117
[PubMed - indexed for MEDLINE]
15.

Cholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemia.

Elshourbagy NA, Meyers HV, Abdel-Meguid SS.

Med Princ Pract. 2014;23(2):99-111. doi: 10.1159/000356856. Epub 2013 Dec 11. Review.

PMID:
24334831
[PubMed - indexed for MEDLINE]
16.

Is the superiority of apoB over non-HDL-C as a marker of cardiovascular risk in the INTERHEART study due to confounding by related variables?

Sniderman AD, Islam S, Yusuf S, McQueen MJ.

J Clin Lipidol. 2013 Nov-Dec;7(6):626-31. doi: 10.1016/j.jacl.2013.08.004. Epub 2013 Aug 31.

PMID:
24314360
[PubMed - indexed for MEDLINE]
17.

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

de Nijs T, Sniderman A, de Graaf J.

Crit Rev Clin Lab Sci. 2013 Nov;50(6):163-71. doi: 10.3109/10408363.2013.847897. Review.

PMID:
24295059
[PubMed - indexed for MEDLINE]
18.

APOE p.Leu167del mutation in familial hypercholesterolemia.

Awan Z, Choi HY, Stitziel N, Ruel I, Bamimore MA, Husa R, Gagnon MH, Wang RH, Peloso GM, Hegele RA, Seidah NG, Kathiresan S, Genest J.

Atherosclerosis. 2013 Dec;231(2):218-22. doi: 10.1016/j.atherosclerosis.2013.09.007. Epub 2013 Sep 19.

PMID:
24267230
[PubMed - indexed for MEDLINE]
19.

Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease.

Boronat M, García-Cantón C, López-Ríos L, Quevedo V, Lorenzo DL, Batista F, Riaño M, Nóvoa FJ.

Diab Vasc Dis Res. 2014 Jan;11(1):53-9. doi: 10.1177/1479164113511834. Epub 2013 Nov 19.

PMID:
24254975
[PubMed - indexed for MEDLINE]
Free Article
20.

Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study.

Voros S, Joshi P, Qian Z, Rinehart S, Vazquez-Figueroa JG, Anderson H, Elashoff M, Murrieta L, Karmpaliotis D, Kalynych A, Brown C 3rd, Schaefer E, Asztalos B.

J Am Heart Assoc. 2013 Nov 19;2(6):e000344. doi: 10.1161/JAHA.113.000344.

PMID:
24252842
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk